Literature DB >> 16039907

Custom zinc-finger nucleases for use in human cells.

Stephen Alwin1, Maja B Gere, Eva Guhl, Karin Effertz, Carlos F Barbas, David J Segal, Matthew D Weitzman, Toni Cathomen.   

Abstract

Genome engineering through homologous recombination (HR) is a powerful instrument for studying biological pathways or creating treatment options for genetic disorders. In mammalian cells HR is rare but the creation of targeted DNA double-strand breaks stimulates HR significantly. Here, we present a method to generate, evaluate, and optimize rationally designed endonucleases that promote HR. The DNA-binding domains were synthesized by assembling predefined zinc-finger modules selected by phage display. Attachment of a transcriptional activation domain allowed assessment of DNA binding in reporter assays, while fusion with an endonuclease domain created custom nucleases that were tested for their ability to stimulate HR in episomal and chromosomal gene repair assays. We demonstrate that specificity, expression kinetics, and protein design are crucial parameters for efficient gene repair and that our two-step assay allows one to go quickly from design to testing to successful employment of the custom nucleases in human cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16039907     DOI: 10.1016/j.ymthe.2005.06.094

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  71 in total

Review 1.  Zinc-finger nucleases for somatic gene therapy: the next frontier.

Authors:  Shamim H Rahman; Morgan L Maeder; J Keith Joung; Toni Cathomen
Journal:  Hum Gene Ther       Date:  2011-07-22       Impact factor: 5.695

2.  Re-programming DNA-binding specificity in zinc finger proteins for targeting unique address in a genome.

Authors:  Abhinav Grover; Akshay Pande; Krishna Choudhary; Kriti Gupta; Durai Sundar
Journal:  Syst Synth Biol       Date:  2011-02-19

3.  Retargeting sleeping beauty transposon insertions by engineered zinc finger DNA-binding domains.

Authors:  Katrin Voigt; Andreas Gogol-Döring; Csaba Miskey; Wei Chen; Toni Cathomen; Zsuzsanna Izsvák; Zoltán Ivics
Journal:  Mol Ther       Date:  2012-07-10       Impact factor: 11.454

4.  Unexpectedly high copy number of random integration but low frequency of persistent expression of the Sleeping Beauty transposase after trans delivery in primary human T cells.

Authors:  Xin Huang; Kari Haley; Marianna Wong; Hongfeng Guo; Changming Lu; Andrew Wilber; Xianzheng Zhou
Journal:  Hum Gene Ther       Date:  2010-10-19       Impact factor: 5.695

5.  Induction and repair of zinc-finger nuclease-targeted double-strand breaks in Caenorhabditis elegans somatic cells.

Authors:  Jason Morton; M Wayne Davis; Erik M Jorgensen; Dana Carroll
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-23       Impact factor: 11.205

Review 6.  Targeted gene therapies: tools, applications, optimization.

Authors:  Olivier Humbert; Luther Davis; Nancy Maizels
Journal:  Crit Rev Biochem Mol Biol       Date:  2012 May-Jun       Impact factor: 8.250

7.  Coevolution of a homing endonuclease and its host target sequence.

Authors:  Michelle Scalley-Kim; Audrey McConnell-Smith; Barry L Stoddard
Journal:  J Mol Biol       Date:  2007-08-02       Impact factor: 5.469

8.  Expanding or restricting the target site repertoire of zinc-finger nucleases: the inter-domain linker as a major determinant of target site selectivity.

Authors:  Eva-Maria Händel; Stephen Alwin; Toni Cathomen
Journal:  Mol Ther       Date:  2008-11-11       Impact factor: 11.454

Review 9.  Progress and prospects of engineered sequence-specific DNA modulating technologies for the management of liver diseases.

Authors:  Samantha A Nicholson; Buhle Moyo; Patrick B Arbuthnot
Journal:  World J Hepatol       Date:  2015-04-28

Review 10.  Custom-designed zinc finger nucleases: what is next?

Authors:  J Wu; K Kandavelou; S Chandrasegaran
Journal:  Cell Mol Life Sci       Date:  2007-11       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.